Skip to main content
Home
  • en
  • fr
  • Profile
    • About DEINOVE
    • Board of Directors
    • Executive Committee
    • Founders
    • A word from the CEO
  • Antibiotics
    • About
    • Antimicrobial resistance
    • Portfolio
    • The AGIR program
    • Discovery platform
    • Partners
  • Bioactives
    • About
    • Biodiversity
    • Portfolio
    • Platform of Expertise
    • Partners
  • Investor room
    • Corporate governance
    • DEINOVE Shares
    • Financial Calendar
    • Documentation Center
    • Press releases
    • Investor relations
  • News & events
    • Press releases
    • Events
    • Press coverage
  • Careers
    • Join DEINOVE
    • Open positions
  1. Home
  2. Site map

Site map

  • Profile
    • About DEINOVE
    • Board of Directors
    • Executive Committee
    • Founders
    • A word from the CEO
  • Antibiotics
    • About
    • Antimicrobial resistance
    • Portfolio
      • DNV3837 / DNV3681
        • DNV3837 Update for ECCMID2019
      • DNB101/102
    • The AGIR program
    • Discovery platform
    • Partners
  • Bioactives
    • About
    • Biodiversity
    • Portfolio
      • Phyt-N-Resist®
      • HEBELYS®
      • Programs under development
    • Platform of Expertise
    • Partners
      • Available ingredient Candidates
  • Investor room
    • Corporate governance
      • Board of Directors
      • Executive Committee
    • DEINOVE Shares
    • Financial Calendar
    • Documentation Center
      • Financial Reports
      • Investor presentations
      • Analyst Coverage
      • Newsletter to Shareholders
      • Shareholders' Meetings
        • Extraordinary Shareholders' Meeting | 5 December, 2019
        • Annual Shareholders' Meeting | May 20, 2019
      • Shares and Voting Rights
      • Transactions on company securities
      • Liquidity Agreement
      • Public offerings - Documentation
      • Obligations Convertibles en Actions (OCA)
    • Press releases
    • Investor relations
  • News & events
    • Press releases
    • Events
      • Past events
    • Press coverage
  • Careers
    • Join DEINOVE
    • Open positions
  • Contact
  • Location
  • Legal Info
  • Site map
  • Privacy Policy
  • Contact
  • Location
  • Legal Info
  • Site map
  • Privacy Policy

Profile

  • About DEINOVE
  • Board of Directors
  • Executive Committee
  • Founders
  • A word from the CEO

Antibiotics

  • About
  • Antimicrobial resistance
  • Portfolio
  • The AGIR program
  • Discovery platform
  • Partners

Bioactives

  • About
  • Biodiversity
  • Portfolio
  • Platform of Expertise
  • Partners

Investor room

  • Corporate governance
  • DEINOVE Shares
  • Financial Calendar
  • Documentation Center
  • Press releases
  • Investor relations

Careers

  • Join DEINOVE
  • Open positions

News & events

  • Press releases
  • Events
  • Press coverage

Downloads

  • Investor presentations
  • Analyst Coverage
  • Financial Reports

Follow us

Stay in touch

Subscribe to our newsletter

Contact us

ZAC Euromédecine II, Cap Sigma, 1682 Rue de la Valsière, 34790 Grabels, France

+33 (0)4 48 19 01 00

Home